Magnus Medical, Inc.
SAINT, a non-invasive neuromodulation system for rapid depression treatment
New patent ·
- Sector
- Medtech
- Headquarters
- BURLINGAME, CA
- Founded
- 2020
- Latest Form D
- $23.7M, May 2025
- Total capital
- $64M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $64M
- 2 Form D · last May 2025
- 17 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 20 pending · first 2026
- Rank in peer group#498 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$23.7M
- Private capital raisedForm D · SEC · 1st filing$40.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#498 · top 45%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Achal AchrolExecutive Officer, DirectorNamed in SEC Form D filings
- Andrew FirlikDirectorNamed in SEC Form D filings
- Brandon BentzleyDirectorNamed in SEC Form D filings
- Christian GormsenExecutive Officer, DirectorNamed in SEC Form D filings
- Heath LukatchDirectorNamed in SEC Form D filings
- Nolan WilliamsDirectorNamed in SEC Form D filings
Show all 8 people
- Vikram LambaExecutive OfficerNamed in SEC Form D filings
- Xingjuan ChaoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 21- New patentSystems And Methods For Determining Therapeutic Neurostimulation ThresholdsUSPTOUS 12,758,789
- PendingSystems And Methods For Determining Therapeutic Neurostimulation ThresholdsUSPTOApplication 18523638
- PendingSystems And Methods For Generating Head ModelsUSPTOApplication 18497892
Show all 21 patent records
- Systems And Methods For Determining Therapeutic Neurostimulation ThresholdsOct 13, 2026 · US 12,758,789Granted
- Systems And Methods For Determining Therapeutic Neurostimulation ThresholdsJun 27, 2024 · Application 18523638Pending
- Systems And Methods For Generating Head ModelsMay 2, 2024 · Application 18497892Pending
- Systems And Methods For Predicting Effectiveness Of TreatmentApr 11, 2024 · Application 18482553Pending
- Methods And Systems For Identification Of Treatment TargetsJan 4, 2024 · Application 18117350Pending
- Methods And Systems For Treatment Of Neuropsychiatric DisordersDec 28, 2023 · Application 18117351Pending
- Methods And Systems For Long Term Treatment Of Neuropsychiatric DisordersSep 22, 2022 · Application 17700451Pending
- Methods And Systems For Identification Of Treatment TargetsApplication PCTUS2023063722Pending
- Systems And Methods For Determining Therapeutic Stimulation Threshold For Transcranial Magnetic StimulationApplication 63385367Pending
- Method For Head Mri Approximation And Reconstruction Using A Morphable Head ModelApplication 63381414Pending
- Systems And Methods For Predicting Effectiveness Of TreatmentApplication 63378781Pending
- Methods And Systems For Selection Of Treatment TargetsApplication 63369729Pending
- System And Method For Determining A Treatment ScheduleApplication PCTUS2022021227Pending
- Methods And Systems For Identification Of Treatment TargetsApplication 63316345Pending
- Methods And Systems For Treatment Of Neuropsychiatric DisordersApplication 63316330Pending
- System And Method For Determining A Treatment ScheduleApplication 63164261Pending
- Systems And Methods For Determining Therapeutic Neurostimulation ThresholdsApplication PCTUS2023081659Pending
- Systems And Methods For Generating Head ModelsApplication PCTUS2023078243Pending
- System And Method For Predicting Effectiveness Of TreatmentApplication PCTUS2023076246Pending
- Systems And Methods For Determining Therapeutic Stimulation Threshold For Transcranial Magnetic StimulationApplication 63450338Pending
- Methods And Systems For Treatment Of Neuropsychiatric DisordersApplication PCTUS2023063723Pending
Related companies, and why
- LUCIE MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- VELLUM BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- ENDONOVO THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- Avivomed Inc.Similar federal contract value in Medtech · null in contracts
- DurVena, Inc.Similar federal contract value in Medtech · null in contracts
- ANTIXEROSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .